Your browser doesn't support javascript.
loading
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.
Gligorov, Joseph; Doval, Dinesh; Bines, José; Alba, Emilio; Cortes, Paulo; Pierga, Jean-Yves; Gupta, Vineet; Costa, Rômulo; Srock, Stefanie; de Ducla, Sabine; Freudensprung, Ulrich; Mustacchi, Giorgio.
Affiliation
  • Gligorov J; Assistance-Publique Hôpitaux de Paris-Tenon, Institut Universitaire de Cancerologie Université Pierre et Marie Curie, Sorbonne Université, Paris, France. Electronic address: joseph.gligorov@tnn.aphp.fr.
  • Doval D; Rajiv Gandhi Cancer Institute & Research Center, Delhi, India.
  • Bines J; Instituto Nacional de Cancer, Rio de Janeiro, Brazil.
  • Alba E; Hospital Universitario Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.
  • Cortes P; University Hospital of Santa Maria, Lisbon, Portugal.
  • Pierga JY; Institut Curie, Université Paris Descartes, Paris, France.
  • Gupta V; Sakra World Hospital, Bangalore, India.
  • Costa R; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.
  • Srock S; F Hoffmann-La Roche, Basel, Switzerland.
  • de Ducla S; F Hoffmann-La Roche, Basel, Switzerland.
  • Freudensprung U; F Hoffmann-La Roche, Basel, Switzerland.
  • Mustacchi G; Medical Oncology, University of Trieste, Trieste, Italy.
Lancet Oncol ; 15(12): 1351-60, 2014 Nov.
Article in En | MEDLINE | ID: mdl-25273343

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Taxoids / Deoxycytidine / Antibodies, Monoclonal, Humanized / Fluorouracil Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Taxoids / Deoxycytidine / Antibodies, Monoclonal, Humanized / Fluorouracil Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article